Hypnotherapy for Functional Dyspepsia
Gut-directed hypnotherapy as a complementary therapy for Rome IV functional dyspepsia. Postprandial distress syndrome (PDS) and epigastric pain syndrome (EPS). Addresses the visceral hypersensitivity, impaired gastric accommodation, and gut-brain patterns that PPIs and prokinetics often leave untouched. Not a replacement for medical diagnosis or treatment.
Important for FD patients: Hypnotherapy is complementary care, not a substitute for medical diagnosis or treatment. Hypnotherapy is not a regulated health profession in Alberta. Functional dyspepsia requires a completed medical workup. H. pylori testing, physician assessment, rule-out of red-flag features, and, where indicated, upper endoscopy. This service addresses the visceral hypersensitivity and gut-brain layer of FD and is only appropriate alongside a physician-led treatment pathway.
Functional dyspepsia is not a problem of too much acid. That is why PPIs only work for some patients. Gut-directed hypnotherapy targets the layer PPIs and prokinetics do not reach: visceral hypersensitivity in the upper GI, impaired gastric accommodation, vagal tone, and the central processing of meal-related sensation.
This is not a page selling you an alternative to your PPI, your prokinetic, or your gastroenterologist. It is a page about the specific, narrow role gut-directed hypnotherapy plays for Rome IV functional dyspepsia. Addressing the visceral hypersensitivity, accommodation, and gut-brain layer that medication-only approaches do not fully cover. The primary treatment pathway for FD is medical. This is the complementary adjunct.
Could Gut-Directed Hypnotherapy Work for You?
60-second hypnotizability quiz. No sign-up needed
Hypnotizability Assessment
Adapted from the Stanford & Tellegen clinical scales
When reading a book or watching a movie, do you get so absorbed you lose track of time?
Read this before booking. What this FD service does and does not do
This service DOES
- Reduce visceral hypersensitivity in the upper GI
- Support gastric accommodation via vagal tone
- Address food-related anxiety & post-meal dread
- Work alongside PPIs, prokinetics & dietary work
This service does NOT
- Replace your PPI, prokinetic, or physician care
- Treat H. pylori, ulcer, or erosive disease
- Substitute for endoscopy or GI workup
- Cure gastroparesis or structural disease
What functional dyspepsia actually is
Functional dyspepsia (FD) is a Rome IV-defined disorder of gut-brain interaction that produces chronic upper-GI symptoms. Centred on the stomach and upper abdomen. In the absence of structural, metabolic, or biochemical abnormality that could explain them. Prevalence estimates commonly cited in gastroenterology reviews put the global adult figure at roughly 10–15%, which makes FD one of the most common chronic GI conditions in primary care.
The Rome IV diagnostic framework splits FD into two subtypes, which frequently overlap in the same patient. Each subtype has a somewhat different mechanistic profile and a somewhat different response pattern to standard treatments, which is part of why a single FD diagnosis does not predict a single FD treatment.
Postprandial distress syndrome (PDS)
Symptoms triggered by or worsened by meals. Specifically postprandial fullness that interferes with normal eating, or early satiety that prevents finishing a normal-sized meal. Bloating in the upper abdomen, postprandial nausea, and excessive belching frequently accompany the core features. The underlying mechanism is typically impaired gastric accommodation (the stomach not relaxing properly to receive food) plus visceral hypersensitivity to normal gastric distension. PDS is the more common subtype.
Epigastric pain syndrome (EPS)
Bothersome upper abdominal pain or burning, severe enough to interfere with daily activity, that is not exclusively meal-related and does not fit the distension-heavy PDS picture. EPS can be intermittent, can be partially meal-related, and shares features with both GERD and peptic ulcer disease. Part of why the workup matters. The underlying mechanism usually involves visceral hypersensitivity, occasional low-grade duodenal immune activation, and in some patients a subtle acid-related component.
Overlap (PDS + EPS) & FD-IBS
A significant minority of FD patients meet criteria for both PDS and EPS simultaneously. A roughly one-third subgroup also meets Rome IV IBS criteria (FD-IBS overlap), which is expected given the shared gut-brain-axis mechanism across the functional GI disorder spectrum. Patients with overlap presentations often have the highest symptom burden and the strongest anxiety comorbidity, and are often the patients for whom behavioural interventions like gut-directed hypnotherapy have the clearest role.
Functional dyspepsia is often misdiagnosed as "gastritis," GERD, or simply lumped under the generic "indigestion" label. The distinction matters because treatment differs. True gastritis (histologically confirmed inflammation, most commonly from H. pylori) needs antibiotic eradication therapy. GERD responds well to PPIs and lifestyle management. Gastroparesis needs motility agents and specific dietary adjustments. FD responds to a combination of reassurance, selective PPI or prokinetic trials, targeted behavioural therapy, and neuromodulator medications in refractory cases. Not PPIs alone, and not antibiotics at all.
Why standard FD treatments often fall short
Most patients who arrive interested in hypnotherapy for functional dyspepsia have already tried the standard medical options. PPIs, prokinetics, dietary modification, sometimes antidepressant neuromodulators. And found the response partial, inconsistent, or tolerably-bad-rather-than-good. That is the typical pattern. It is not patient failure; it is a reflection of the fact that the standard medication toolbox is aimed at only some of the mechanisms producing FD symptoms.
The standard medication options for FD each address a partial slice of the mechanism.
Proton pump inhibitors (PPIs)
A reasonable first-line trial, particularly for EPS. Pooled response rates across published FD trials typically sit around 30–40%, meaning most patients do not get meaningful benefit. PPIs target acid secretion, which is meaningfully relevant in a minority of FD patients. Those with an EPS or overlap-GERD profile. They do nothing for gastric accommodation, do nothing for visceral hypersensitivity, and often leave PDS-dominant patients essentially unchanged. Long-term PPI use also has documented safety concerns that inform the risk-benefit conversation with your physician.
Prokinetics (domperidone, metoclopramide, itopride)
Target delayed gastric emptying and impaired motility. Response rates published across FD trials typically sit in the 20–30% range for meaningful symptom improvement. Prokinetics can genuinely help the subgroup with documented delayed emptying or clear motility-pattern PDS, but the benefit plateau is modest, and side-effect profiles (cardiac QT considerations, neurological effects, hormonal effects) limit long-term use for many patients. Metoclopramide has specific long-term safety warnings.
H. pylori eradication
For the subset of FD patients who test positive for H. pylori, eradication therapy (triple or quadruple antibiotics) can produce durable symptom improvement in roughly 10% of cases. A real signal, and reason enough to test and treat when positive, but not a treatment that benefits H. pylori-negative FD patients at all. Testing and treatment is standard Rome IV-era practice.
Neuromodulators (TCAs, SSRIs, buspirone, mirtazapine)
Low-dose tricyclic antidepressants, selected SSRIs, buspirone, and mirtazapine are used for refractory FD, particularly EPS with visceral pain or overlap anxiety. They act on central pain processing and, in some cases, gastric accommodation. These are real tools for a subgroup. They are also medication decisions made with your physician. Not hypnotherapy decisions.
Dietary modification
Smaller, more frequent meals; reduced fat; reduced spicy or heavily-seasoned foods; alcohol and caffeine moderation; trigger identification. Most FD patients find diet modification helpful for symptom smoothing, particularly for PDS, but few find it completely resolving. Rigid elimination diets are usually unnecessary and can themselves contribute to food-anxiety. A pattern gut-directed hypnotherapy often addresses alongside nutrition work.
This is the clinical gap that makes the gut-directed hypnotherapy conversation rational. Each standard tool helps some patients partially; none of them targets visceral hypersensitivity or gastric accommodation directly. That is the specific territory where behavioural therapies, and gut-directed hypnotherapy in particular, have a mechanistic reason to add value on top of the medical layer. Not as a replacement for it.
Meta-analyses of PPI trials in functional dyspepsia consistently put therapeutic gain above placebo in the 30–40% range, with the best responders being those with EPS or overlap-GERD features. This leaves roughly 60% of FD patients without meaningful PPI benefit. The conceptual target population for adding a gut-brain intervention.
Source: Pooled FD PPI trial data; figure reflects commonly-cited ranges in gastroenterology reviews
Partial response to PPIs or prokinetics?
If medications are helping a little but not resolving your FD, the gap is often in the visceral hypersensitivity and gut-brain layer that medication does not target. The free 15-minute fit consultation is a low-friction way to see whether hypnotherapy fits your picture.
Book the free consult →The gut-brain axis in functional dyspepsia
Rome IV explicitly reframed functional dyspepsia. Alongside IBS, functional heartburn, and related conditions. As a disorder of gut-brain interaction. This is not a metaphor. It is a descriptive claim about where the problem sits: not solely in the stomach, not solely in the brain, but in the bidirectional signalling pathways between them. Three specific dimensions matter for FD, and each is a plausible target for gut-directed hypnotherapy.
1. Visceral hypersensitivity of the upper GI
Barostat studies have repeatedly shown that many FD patients perceive normal gastric distension as painful or distressing. The same volume of stomach stretch that a non-FD control tolerates comfortably feels full, painful, or anxiety-triggering to an FD patient. This is the upper-GI counterpart of the colonic visceral hypersensitivity well documented in IBS, and it is a core mechanism behind PDS in particular. Reducing visceral amplification is one of the most consistent effects of gut-directed hypnotherapy across the condition spectrum.
2. Impaired gastric accommodation
Under normal function, the proximal stomach (the fundus) relaxes to receive incoming food. A vagally-mediated reflex that allows a normal meal to be accepted without distension-driven symptoms. In many PDS patients this accommodation is measurably impaired: the stomach does not relax as it should, volumes build pressure quickly, and early satiety and postprandial fullness result. Because accommodation is under vagal control, interventions that improve parasympathetic tone have a plausible physiological route into this mechanism.
3. Central processing & attention to gut sensation
Functional MRI and related neuroimaging studies show that FD patients, like IBS patients, exhibit heightened central processing of afferent gut signals , the same physiological signal produces a larger cortical response. Over time, this central amplification feeds an attentional loop: gut sensation becomes more prominent, attention to meals becomes vigilant, and every meal becomes a threat-assessment exercise rather than a routine event. Targeted hypnotherapeutic suggestion addresses this central amplification and attentional pattern directly.
The practical implication is that FD treatment is most effective when it addresses more than one of these dimensions at once. Medications can sometimes partially address one. Usually either the acid contribution (PPIs) or the motility piece (prokinetics). Gut-directed hypnotherapy is specifically built to address the visceral-amplification and central-processing layers that medications do not touch, and to indirectly support accommodation via vagal-tone mechanisms. Combining the layers is typically more productive than cycling through options one at a time.
Gastric accommodation. The reflex that allows the proximal stomach to relax for a meal. Is a parasympathetic (vagal) function. Interventions that improve vagal tone, including clinical hypnosis with targeted gastric imagery, have a direct biological route to support accommodation and reduce early satiety and postprandial fullness.
Source: Standard autonomic and GI physiology; well documented in accommodation literature
How gut-directed hypnotherapy helps functional dyspepsia
With the mechanism picture in place, the FD-specific role of gut-directed hypnotherapy becomes concrete rather than vague. It is not "stress reduction" as a generic wellness claim. It is four specific levers, each of which maps onto a documented mechanism of functional dyspepsia.
1. Reduced visceral hypersensitivity in the upper GI
The same visceral-sensitivity reduction that gives gut-directed hypnotherapy its effect in IBS applies to the stomach. Targeted imagery and suggestion around gastric comfort, stretch tolerance, and post-meal calm work directly on the sensory-amplification pathway that drives PDS early satiety and EPS epigastric pain. Miller 2015 (PMID 25736234) reported a 76% response rate on the Manchester Protocol across 1,000 refractory IBS patients with visceral hypersensitivity reduction as a key component of response. The same mechanism that maps onto FD.
2. Improved vagal tone & gastric accommodation
Clinical hypnosis reliably shifts the autonomic balance toward parasympathetic dominance during and after sessions, documented by heart-rate-variability measurements across multiple studies. Because gastric accommodation is a vagal-reflex function, better vagal tone has a direct physiological route to improved accommodation. The specific mechanism underneath postprandial fullness and early satiety in PDS.
3. Reduced central threat-weighting of meals
FD patients frequently develop a learned, attentional pattern where meals are anticipated as threat events. "I can't finish, I'll feel sick, I will be in pain." This attentional loop itself amplifies symptoms by priming the central processing apparatus for threat. Gut-directed hypnotherapy specifically addresses this attentional pattern: meals are rehearsed at the imagery level as routine, manageable, and non-threatening, with accompanying suggestion around calm gastric function. Clients typically notice this as less anticipatory dread before eating.
4. Reduced food-avoidance & safer eating patterns
Many FD patients. Particularly those with severe PDS. Have retracted their eating into a short list of "safe" foods and small grazing meals, a pattern which can itself perpetuate the problem by keeping the gastric accommodation reflex under-trained and the food-threat association reinforced. As the hypnotherapy work reduces anticipatory anxiety, most FD clients are able to gradually reintroduce normal meal sizes and food variety. Which itself retrains the accommodation pattern. This is work done alongside a registered dietitian where appropriate.
Note what this list does not include. Gut-directed hypnotherapy does not lower stomach acid, does not treat H. pylori, does not resolve peptic ulcer disease, and does not act as a prokinetic agent pharmacologically. The mechanism is entirely through the autonomic nervous system, gut-brain signalling, and central processing . The exact layers that medications do not target. That is a narrow but real lane, and it happens to be the specific lane where standard FD treatments fall short.
Miller 2015 (PMID 25736234) reported a 76% response rate on the Manchester Protocol in 1,000 refractory IBS patients. The largest clinical audit of gut-directed hypnotherapy. FD and IBS share core gut-brain mechanisms (visceral hypersensitivity, dysregulated central processing), which is why the mechanistic rationale transfers to functional dyspepsia.
Source: Miller 2015 (PMID 25736234)
Research: Calvert, Chiarioni & the FD evidence base
The trial base for gut-directed hypnotherapy in functional dyspepsia specifically is smaller than the IBS literature. But it exists, and the results are clinically meaningful. Two studies stand out as the most-cited anchor points, and the broader IBS and gut-directed hypnotherapy literature informs the rest.
Calvert and colleagues, 2002. The Whorwell FD trial
The first rigorous trial of gut-directed hypnotherapy specifically for functional dyspepsia, conducted at the Manchester gastroenterology service under Peter Whorwell. 126 patients with functional dyspepsia were randomised to three arms: hypnotherapy, supportive therapy plus placebo medication, or standard medical management. At the end of treatment and at 56 weeks, the hypnotherapy arm showed significantly greater symptom improvement, greater quality-of-life gains, and. Notably. Reduced need for ongoing medication compared to the supportive or medical arms. The benefit was sustained at long-term follow-up. This is the single most important FD-specific trial in the gut-directed hypnotherapy literature.
Chiarioni and colleagues, 2006. Sustained benefit replication
A subsequent Italian trial evaluating gut-directed hypnotherapy in functional dyspepsia, broadly replicating the Calvert / Whorwell findings. Patients receiving hypnotherapy showed significant symptom improvement and sustained benefit at follow-up, with reduced medication use compared to control. The replication is meaningful because it moves the evidence base from a single centre (Manchester) to independent confirmation.
Miller 2015 (PMID 25736234). Manchester Protocol audit (IBS)
Miller and colleagues published a clinical audit of 1,000 refractory IBS patients treated with the Manchester Protocol of gut-directed hypnotherapy, reporting a 76% response rate. The population is IBS rather than FD, but the Manchester Protocol itself evolved out of the same clinical group that ran the Calvert FD study, and the mechanistic rationale for hypnotherapy in FD draws heavily on the IBS evidence base because the underlying gut-brain-axis mechanism is shared.
Peters 2016 (PMID 27397586). GDH vs low-FODMAP in IBS
A randomised trial comparing gut-directed hypnotherapy to the low-FODMAP diet in IBS. Both arms produced equivalent GI symptom improvement; hypnotherapy was superior on anxiety and depression measures, with gains durable at 6-month follow-up. The relevance for FD is that many FD patients use dietary restriction as their primary behavioural intervention. Peters 2016 supports layering hypnotherapy in rather than relying on dietary restriction alone.
Honest framing: the FD-specific gut-directed hypnotherapy trial base is smaller than the IBS base, and more recent, larger trials in FD specifically would strengthen the picture. What we do have. Calvert 2002, Chiarioni 2006, plus the broader mechanistic evidence base from IBS. Supports a reasonable, mechanistically coherent case for including gut-directed hypnotherapy as a complementary layer in FD management, particularly for PDS-dominant and overlap presentations that respond poorly to medications alone. It is not a case for replacing medical management.
Calvert-trial profile sound familiar?
The patients who benefited most in the Calvert 2002 and Chiarioni 2006 trials had chronic, refractory PDS-dominant or overlap FD with clear meal-triggered postprandial distress. If that matches you, the fit consultation is a reasonable next step.
Book the free consult →Combined protocol: medical workup + GDH + lifestyle
The way this works in practice is a sequenced combination, not an either/or choice between medical and behavioural care. Four steps, run in the right order, make up the protocol. The first two are medical or diagnostic; the third is the hypnotherapy work; the fourth is lifestyle and dietary integration.
Step 1. GI workup & Rome IV diagnosis
Physician assessment with a red-flag screen (weight loss, GI bleeding, vomiting, dysphagia, anemia, new-onset symptoms after age 55, family history of upper GI cancer). Basic blood work. Upper endoscopy where indicated. Positive Rome IV diagnosis of PDS, EPS, or overlap. This is a medical step, not a hypnotherapy step.
Step 2. H. pylori test and treat
Stool antigen test, urea breath test, or biopsy-based testing during endoscopy. If positive, eradication therapy (triple or quadruple antibiotic regimen) under your physician. This benefits approximately 10% of FD patients durably. A real, addressable subset that it would be negligent to skip.
Step 3. Appropriate medical treatment trial
For EPS-dominant or overlap presentations: PPI trial (4–8 weeks) under your physician. For PDS-dominant presentations: prokinetic trial (domperidone or itopride where available). For refractory cases with clear visceral pain or overlap anxiety: neuromodulator consideration with your prescribing physician. Each is a partial-response tool. And each is a decision made medically, not behaviourally.
Step 4. Gut-directed hypnotherapy as the adjunct layer
The work this service delivers. A 3-session commitment, ideally started during or after the initial medication trial so the hypnotherapy is adding value on top of whatever the medication has already produced. This addresses the visceral-hypersensitivity, accommodation, and central-processing layers that medications do not target.
Step 5. Lifestyle and dietary integration
Smaller, more frequent meals; reduced fat and spicy foods; alcohol and caffeine moderation; sleep regularity; stress management practices; gentle movement. Rigid elimination diets usually unnecessary. Referral to a registered dietitian for patients with significant food retraction or overlap IBS-FD eating pattern concerns. This layer runs concurrently with the hypnotherapy, not after it.
Our 3-session commitment structure for FD
The 3-session commitment for functional dyspepsia uses the same cadence, pricing, and clinical framework as the IBS and SIBO services, with the session content weighted toward upper-GI imagery, gastric accommodation suggestion, and meal-related anxiety rather than the lower-GI emphasis of an IBS-focused program. Each session is 50–60 minutes.
Session 1. FD history, Rome IV mapping, first induction
Full review of your FD history: symptom pattern (PDS, EPS, overlap), duration, meal-trigger profile, medication history (PPIs, prokinetics, neuromodulators), H. pylori status, any completed endoscopy, overlap anxiety or IBS features, and specific high-symptom scenarios (restaurant meals, travel, large meals, particular foods). Plain-language education on the gut-brain axis as it applies to FD specifically. First induction with suggestions oriented toward gastric calm, accommodation, and postprandial comfort, followed by a personalised home-practice audio.
Session 2. Deepening, meal-specific imagery, trigger work
Review of the first week. Home-practice adherence, symptom tracking, any changes in postprandial fullness, early satiety, epigastric pain, or meal-related anxiety. Deeper induction with targeted suggestions around meal-specific scenarios that tend to trigger symptoms (restaurant anxiety, social eating, travel meals, particular food categories), plus continued accommodation and gastric-comfort imagery. The audio is refined based on what the week revealed.
Session 3. Consolidation, maintenance plan, review
Consolidation of the visceral-sensitivity, accommodation, and meal-attentional work. A practical maintenance plan: home-practice cadence, symptom-flag monitoring, meal-size progression where appropriate, and coordination with any ongoing medical treatment. An honest review against the symptom-tracking baseline from session 1. This is the decision point: wrap with the audio as maintenance, extend for 2–3 additional spaced sessions if helpful, or. If session 3 has not produced meaningful change , a frank conversation about what might be a better fit (further GI workup, dietitian referral, neuromodulator discussion with your physician, structured CBT-GI).
Between sessions, FD clients get the same inter-session email support as any other client, with specific attention to meal-timing and meal-size questions that come up in the first weeks. A simple symptom tracker. Postprandial fullness intensity, early-satiety frequency, epigastric pain episodes, meal anxiety ratings. Gives us concrete data to adjust the protocol session by session.
For FD clients who are also IBS-positive (the roughly one-third overlap population), the session content blends upper and lower GI work: gastric accommodation and postprandial comfort from the FD template, combined with the visceral-sensitivity and bowel-pattern work from the IBS template. The session count, cadence, and price remain the same; the content density increases.
For FD clients whose symptoms have been present for many years with strong anxiety overlap, continuation beyond session 3 is usually structured as 2–3 spaced follow-ups (for example, one at 6 weeks and one at 3 months) rather than continued weekly work. Consolidation and flag review rather than ongoing active therapy. Patients who have not meaningfully responded by session 3 are referred back to their physician or a CBT-GI clinician for alternative approaches; this service does not continue indefinitely when the evidence of response is absent.
Who FD hypnotherapy is best suited for
Within the complementary lane described above, certain FD profiles have the clearest mechanistic rationale for adding gut-directed hypnotherapy. If you recognise yourself in one of these, the fit consultation is a reasonable next step.
PDS-dominant, poor PPI response
Classic fit. Postprandial fullness, early satiety, and upper bloating dominate your picture; PPIs have been tried and produced little benefit. The visceral-hypersensitivity and accommodation layers are almost certainly central for you, and those are exactly what gut-directed hypnotherapy targets.
EPS with partial PPI response and residual symptoms
Your epigastric pain or burning improved partially on a PPI but you still have meaningful symptom burden. The visceral-pain amplification and central threat-weighting layers are plausible remaining drivers, and hypnotherapy is built for that population.
FD with significant anxiety or food-related fear
Meals have become threat events. You are anxious before eating, hypervigilant during meals, restricted in what you will eat, and your social eating has contracted. This is the central-processing and attentional layer of FD, and it responds particularly well to targeted hypnotherapeutic work alongside continued medical management.
FD-IBS overlap
You meet Rome IV criteria for both FD and IBS. You have postprandial distress or epigastric pain, plus altered bowel habits with pain related to defecation. The overlap population typically has the highest symptom burden and the strongest response signal from gut-directed hypnotherapy, because the intervention addresses the shared gut-brain mechanism underneath both.
FD with long duration and reduced quality of life
Symptoms for years, multiple medication trials, ongoing social and work impact. The Calvert 2002 trial specifically recruited chronic, refractory FD, and that is precisely the population where the trial showed clinically meaningful sustained benefit. If that profile describes you, the FD-specific evidence base is at its most relevant.
Profiles that are not a good fit, and where the fit consultation will redirect you: anyone who has not had a completed medical workup yet; anyone with unexplained red-flag features (significant unexplained weight loss, GI bleeding, persistent vomiting, progressive dysphagia, iron-deficiency anemia, new-onset dyspeptic symptoms after age 55); anyone who has not been tested for H. pylori; anyone with known gastroparesis hoping hypnotherapy will cure it; anyone refusing medical evaluation and hoping hypnotherapy will substitute. For any of these profiles the consultation is free and the redirection is honest. The goal is to point you to the right next step, not to sign you up for a program that does not match your clinical situation.
Recognise your FD profile?
The free 15-minute fit consultation confirms whether your presentation fits the complementary protocol. Or whether a different resource is a better next step.
Book the free consult →Pricing and insurance
Transparent pricing, identical to the main IBS service and the SIBO service. Same rate virtual or in-person. No hidden fees, no booking surcharges, no cancellation penalties within normal notice.
Fit consultation
$0
Free 15-minute video call. Confirms clinical fit given your FD history and workup status.
Recommended starting point
$660 CAD
3-session commitment. $220 × 3. Continuation optional after the review at session 3.
Per session
$220 CAD
Same price virtual (across Canada) or in-person in Calgary. No admin fees.
Hypnotherapy in Canada is generally not directly covered under extended health benefit plans. Some clients can claim related programs (stress management, behavioural change) under a Wellness Spending Account (WSA) if their plan offers one. Coverage rules depend entirely on plan design, so check with your insurance provider before booking. Sessions are paid at time of service, and you receive a detailed receipt (with the practitioner's ARCH registration number) that you can submit for any reimbursement your provider may approve.
Working with your insurance provider
Coverage of hypnotherapy varies entirely by plan design. Before booking, check whether your plan reimburses hypnotherapy directly, and whether you have a Wellness Spending Account that accepts wellness-related receipts. See our full Canadian insurance coverage guide for the three questions to ask your insurer.
When to see a GI specialist first
This is the most important section to take seriously. The question is not whether you should eventually book gut-directed hypnotherapy. It is whether your diagnostic and treatment foundation is in place for hypnotherapy to make sense at all. Three clear indications that your next call is to a physician, not to this service.
1. Red-flag features present
Unexplained weight loss, persistent vomiting, gastrointestinal bleeding (visible blood in vomit or stool, black or tarry stools), progressive dysphagia, iron-deficiency anemia, a palpable abdominal mass, family history of upper GI cancer, or new-onset dyspeptic symptoms after age 55. Any of these warrant an urgent gastroenterology evaluation, including endoscopy. They are not features of functional dyspepsia and they are not something hypnotherapy should be addressing.
2. No H. pylori testing completed
H. pylori testing is a standard, inexpensive, non-invasive step that should precede a long-term FD treatment plan. A positive result is directly treatable with antibiotic eradication therapy, and produces durable FD resolution in a meaningful subset. Starting hypnotherapy without ruling out or treating H. pylori is skipping a straightforward answer. If you have not been tested, that is the first call.
3. No physician assessment or endoscopy where indicated
A Rome IV FD diagnosis requires exclusion of structural and biochemical explanations. Depending on your age, symptom duration, and feature profile, your physician may recommend upper endoscopy, basic blood work, celiac screening, or other evaluations. Running a behavioural protocol on an undiagnosed or undifferentiated upper GI picture is poor clinical practice, because conditions that mimic FD (peptic ulcer, early upper GI malignancy, gastroparesis, biliary disease) have treatment pathways of their own.
Frequently asked questions about hypnotherapy for functional dyspepsia
Is functional dyspepsia different from IBS?+
Yes. Functional dyspepsia (FD) and IBS are distinct Rome IV diagnoses, though they share the same underlying gut-brain-axis mechanism and frequently co-occur in the same patient. FD is defined by upper GI symptoms. Postprandial fullness, early satiety, or epigastric pain / burning. And splits into two subtypes: postprandial distress syndrome (PDS) and epigastric pain syndrome (EPS). IBS is defined by lower GI symptoms. Abdominal pain related to defecation, with altered stool form or frequency. The mechanisms are parallel: visceral hypersensitivity, impaired motility and accommodation, gut-brain dysregulation, and low-grade immune activation. The treatment logic also parallels, which is why gut-directed hypnotherapy has a reasonable mechanistic rationale for both. Roughly a third of FD patients also meet IBS criteria, and for those patients the hypnotherapy program addresses both domains together.
Why do PPIs only help some FD patients?+
Because proton pump inhibitors (PPIs) treat an acid problem, and functional dyspepsia is not primarily an acid problem. PPIs suppress gastric acid secretion, which is highly effective for GERD, erosive esophagitis, and peptic ulcer disease. And is a reasonable first-line trial for FD, particularly the epigastric pain syndrome (EPS) subtype, where there may be subtle acid-related contribution. Published response rates for PPIs in FD sit broadly in the 30–40% range, meaning roughly 60% of FD patients do not get meaningful relief from acid suppression. The patients most likely to respond are those with EPS-dominant or overlap-GERD presentations. Patients with classical postprandial distress syndrome (PDS). Early satiety and postprandial fullness without pain. Typically respond poorly to PPIs because the core problem is impaired gastric accommodation and visceral hypersensitivity, not acid. For these patients, addressing the gut-brain layer is often where meaningful improvement comes from. Scope note: changes to PPIs are a physician decision; hypnotherapy does not prescribe or deprescribe medications.
What tests do I need before starting FD hypnotherapy?+
At minimum: an H. pylori test (stool antigen, urea breath test, or biopsy during endoscopy), and a physician assessment to rule out red-flag features. Unexplained weight loss, persistent vomiting, GI bleeding, anemia, progressive dysphagia, a family history of upper GI cancer, or new-onset symptoms after age 55. Depending on your presentation, your physician may also recommend upper endoscopy, a basic blood panel, and celiac screening. Current Rome IV guidance is that FD is a positive diagnosis. Symptoms matching PDS or EPS criteria for at least three months, plus exclusion of structural disease. Running an FD-specific hypnotherapy protocol without a completed workup is poor clinical practice, because conditions that mimic FD (H. pylori gastritis, peptic ulcer, GERD, gastroparesis, gastric cancer in older adults, biliary disease) need their own treatment pathways. If your workup is not complete, the free fit consultation will route you back to your physician before starting any hypnotherapy.
Can GDH replace my PPI for functional dyspepsia?+
No, and the fit consultation will not frame it that way. Any change to a PPI prescription is a decision between you and your prescribing physician, not something hypnotherapy directs. What gut-directed hypnotherapy can do is address a different layer of the problem. The visceral hypersensitivity, impaired gastric accommodation, and gut-brain dysregulation that PPIs do not target. In practice, some FD patients find that as the hypnotherapy work progresses, their upper GI symptom burden reduces enough that they discuss tapering the PPI with their physician. That is a clinical decision made medically, not behaviourally. Other patients continue PPIs long-term and use hypnotherapy for the symptom dimensions PPIs leave untouched. Both outcomes are valid. What this service does not do is tell you to stop your PPI, and anyone who promises that is practising outside scope.
How long does it take to see results for FD with hypnotherapy?+
The 3-session commitment is spread over roughly 3–6 weeks, and most FD clients notice measurable symptom shift somewhere between the end of session 1 and the start of session 3. Typically reductions in postprandial fullness intensity, earlier-recovery after meals, less epigastric tension, and less food-related anxiety. A clearer picture of durable change usually takes 2–3 months from the first session, which is why some clients extend with a small number of spaced follow-ups after session 3. The Calvert 2002 and Chiarioni 2006 studies on hypnotherapy for FD reported sustained benefit at 12-month follow-up, with the FD-specific protocol producing symptom reductions that outlasted the active treatment phase. Your own timeline may be faster or slower depending on duration of FD symptoms, overlap with anxiety or IBS, consistency of home-practice audio use, and whether any contributing medications or lifestyle factors are simultaneously addressed medically.
Is functional dyspepsia the same as "gastritis"?+
No, although the two terms are frequently confused and often used interchangeably in lay conversation. "Gastritis" is a histological diagnosis. Inflammation of the stomach lining on biopsy. Most commonly caused by H. pylori infection, NSAID use, autoimmune processes, or less commonly other irritants. Functional dyspepsia is a clinical diagnosis based on symptoms (postprandial fullness, early satiety, epigastric pain or burning) meeting Rome IV criteria, with no structural or biochemical abnormality on workup. Many patients told they have "gastritis" based on symptoms alone actually have FD. The stomach lining is normal on biopsy, or was never biopsied, and the symptoms come from visceral hypersensitivity and motility dysfunction rather than inflammation. The reverse also happens: patients with true H. pylori gastritis who are incorrectly told they have FD and left without antibiotic treatment for the infection. This is why the H. pylori test and, where indicated, endoscopy with biopsy matter. Treatment differs sharply: biopsy-confirmed H. pylori gastritis needs triple or quadruple antibiotic therapy to eradicate the infection; FD does not.
Can I have both FD and IBS (and does the treatment differ)?+
Yes, very commonly. Roughly one-third of FD patients also meet IBS criteria, and the overlap population is well recognised in the Rome IV framework as an example of the functional GI disorder spectrum. The same gut-brain-axis mechanism producing symptoms in different regions of the gut. For overlap patients, the hypnotherapy program does not change in structure: same 3-session commitment, same price, same ARCH-registered clinician. What shifts is the session content. The standard FD program weights imagery and suggestion toward upper GI symptoms. Gastric accommodation, postprandial comfort, epigastric calming. The IBS program weights the content toward lower GI symptoms. Visceral hypersensitivity in the colon, bowel regularity, bloating. For FD-plus-IBS patients, we blend both, with a practical tracker covering upper and lower GI symptoms so we can see where improvement is landing and adjust session by session. This is more efficient than running two separate condition protocols.
Does Alberta extended health insurance cover FD hypnotherapy?+
Hypnotherapy in Canada is generally not directly covered under extended health benefit plans. Some clients can claim related programs (stress management, behavioural change) under a Wellness Spending Account (WSA) if their plan offers one. Coverage rules depend entirely on plan design, so check with your insurance provider before booking. Sessions are paid at time of service; a detailed receipt (with the practitioner's ARCH registration number) is provided for any reimbursement your provider may approve.
Ready to add the gut-brain layer to your FD treatment?
- Free 15-minute video fit consultation. No obligation
- 3-session commitment ($660 CAD), continuation optional
- Complementary to PPIs, prokinetics, and H. pylori treatment. Not a replacement
- Virtual across Canada or in-person near 4th Ave SW in Calgary
- Detailed receipt for Alberta extended-benefits reimbursement
📅 Currently booking 1–2 weeks out
Related reading: Hypnotherapy for IBS · Hypnotherapy for SIBO · Visceral hypersensitivity · Gut-brain connection · What is gut-directed hypnotherapy? · Apply
About the Author
Danny M.
Registered Clinical Hypnotherapist (RCH) with the Association of Registered Clinical Hypnotherapists (ARCH). 700+ hours of clinical training. Specialises in gut-directed hypnotherapy for IBS, SIBO, functional dyspepsia, and gut-brain anxiety, with particular focus on the visceral-hypersensitivity and gastric-accommodation layer of Rome IV functional dyspepsia. Delivers sessions virtually across Canada and in-person in Calgary near 4th Ave SW. Works strictly as a complement to physician-led FD treatment.
Learn more about our approach